Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuyuki Nakajima

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Current Pharmaceutical Biotechnology|April 18, 2013
Development of a high sensitivity ELISA for the assay of metallothioneinTakeaki Nagamine, Katsuyuki Nakajima
Expert Opinion on Therapeutic Patents|October 8, 2013
Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178Katsuyuki Nakajima, Junji Kobayashi
Current Pharmaceutical Biotechnology|April 18, 2013
Significance of metallothionein expression in liver diseaseTakeaki Nagamine, Katsuyuki Nakajima
Current Opinion in Endocrinology, Diabetes, and Obesity|March 2, 2018
Postprandial remnant lipoproteins as targets for the prevention of atherosclerosisKatsuyuki Nakajima, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 9, 2018
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosisKatsuyuki Nakajima, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2018
Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestineKatsuyuki Nakajima, Yoshiharu Tokita, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 20, 2017
Biological sources of variation of serum adiponectin among healthy individuals in comparison with related nutritional and inflammatory markersYoshihisa Shimizu, Kiyoshi Ichihara, Katsuyuki Nakajima, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 2, 2016
[Possibility of New Circulating Atherosclerosis-Related Lipid Markers Measurement in Medical and Complete Medical Checkups: Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein Lipase]Hiroyuki Sumino, Katsuyuki Nakajima, Masami Murakami
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 2018
Hypothesis: Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesityKatsuyuki Nakajima, Yoshiharu Tokita, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2006
The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasmaKatsuyuki Nakajima, Takamitsu Nakano, Akira Tanaka
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Current Pharmaceutical Biotechnology|April 18, 2013
Development of a high sensitivity ELISA for the assay of metallothioneinTakeaki Nagamine, Katsuyuki Nakajima
Expert Opinion on Therapeutic Patents|October 8, 2013
Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178Katsuyuki Nakajima, Junji Kobayashi
Current Pharmaceutical Biotechnology|April 18, 2013
Significance of metallothionein expression in liver diseaseTakeaki Nagamine, Katsuyuki Nakajima
Current Opinion in Endocrinology, Diabetes, and Obesity|March 2, 2018
Postprandial remnant lipoproteins as targets for the prevention of atherosclerosisKatsuyuki Nakajima, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 9, 2018
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosisKatsuyuki Nakajima, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2018
Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestineKatsuyuki Nakajima, Yoshiharu Tokita, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 20, 2017
Biological sources of variation of serum adiponectin among healthy individuals in comparison with related nutritional and inflammatory markersYoshihisa Shimizu, Kiyoshi Ichihara, Katsuyuki Nakajima, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 2, 2016
[Possibility of New Circulating Atherosclerosis-Related Lipid Markers Measurement in Medical and Complete Medical Checkups: Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein Lipase]Hiroyuki Sumino, Katsuyuki Nakajima, Masami Murakami
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 2018
Hypothesis: Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesityKatsuyuki Nakajima, Yoshiharu Tokita, Akira Tanaka
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2006
The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasmaKatsuyuki Nakajima, Takamitsu Nakano, Akira Tanaka
Pageof 14